Poolbeg Pharma PLC

Poolbeg Pharma PLC

POLBF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$67.41M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Poolbeg Pharma PLCPoolbeg Pharma PLC-7.5--166%--
$0.02

Current Fair Value

82.4% downside

Overvalued by 82.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$67.41 Million
Enterprise Value$62.59 Million
Earnings per Share$-0.01
Beta1.81
Outstanding Shares703,662,758

Return

Return on Equity-166.42%ROE
Return on Assets-156.20%
Return on Invested Capital-177.14%

Valuation & Multiples

P/E Ratio-7.5P/E Ratio
PEG68.63PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-5.27
Enterprise Value to Net Income-6
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 29, 2026
EPS
-$0.00
Est. -$0.00
Revenue Estimate
-
Consensus analyst estimate

Next Earnings Call

Expected Date
March 4, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Poolbeg Pharma PLC

15 employees
CEO: Jeremy Skillington

Poolbeg Pharma plc operates as a clinical-stage pharmaceutical company, headquartered in London, United Kingdom, with a focus on developing treatments for infectious diseases. Its current product pipeline includes: POLB 001: A p38 MAP Ki...